Status:

COMPLETED

Insights From the Retina on Cerebral Microvascular Dysfunction in Haemorrhagic Stroke

Lead Sponsor:

University of Zurich

Conditions:

Intracerebral Hemorrhage

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Fundoscopy, optical coherence tomography (OCT) and OCT-angiography (OCTA) are established examinations and bear minimal risks. The recognition of retinal microvascular signs will enhance the pathophys...

Detailed Description

The purpose of the study is to * To evaluate the feasibility of fundoscopy, OCT and OCTA imaging in the environment of a Neurocritical Care Unit (NCCU) * To detect, quantify and associate microvascul...

Eligibility Criteria

Inclusion

  • All groups
  • Primary ICH or aSAH with symptoms onset \< 3 days
  • 18 to unlimited years of age
  • Signed informed consent obtained from legal representative or patient ICH group
  • Primary ICH localized either in basal ganglia, thalamus, pons or cerebellum aSAH group
  • Ruptured aneurysm visualized in contrast-enhanced computed tomography (angio-CT), MRI or cerebral angiography Control group
  • Stroke due to perimesencepahlic subarachnoid hemorrhage, arteriovenous malformation or isolated traumatic brain injury

Exclusion

  • All groups
  • Cerebral amyloid angiopathy or other neurodegenerative disease
  • History of migraine with aura or ischemic stroke
  • Contraindication for pupil dilation (intracranial hypertension, allergy against mydriatics, angle closure glaucoma)
  • Any pre-existing or manifest ocular condition affecting either the integrity of retinal vessels, transparency of optical media or the risk of acute angle closure glaucoma
  • Concomitant instable critical illness (e.g. sepsis, multi-organ failure)
  • Intracranial pressure \> 20mmHg and refractory to cerebrospinal fluid drainage
  • Pregnancy

Key Trial Info

Start Date :

February 23 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 28 2022

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT04363619

Start Date

February 23 2021

End Date

July 28 2022

Last Update

August 4 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital Zurich

Zurich, Switzerland, CH-8091